We found that individuals carrying both ERCC1 118 and XRCC1 399 variant alleles were at a higher death risk of lung adenocarcinoma than those with only one of them (adjusted HRs were 2.44, 1.79 and 1.64, respectively) (Table 4). This evidence concerns the gene XRCC1 and lung adenocarcinoma.